Recent Updates
Recently added Catalysts
BAX Positive Sentiment

Baxter выпускает гемостатический пластырь HEMOPATCH, коллагеновую накладку комнатной температуры, одобренную для гемостаза и герметизации, подходящую для открытой хирургии и минимально инвазивных хирургических процедур (MIS) «Гемостатический пластырь Hemopatch представляет собой значительную разработку компании Baxter, и внедрение варианта с комнатной температурой...

Tuesday, May 20, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Baxter has launched Hemopatch, a hemostatic patch designed for effective sealing and hemostasis during surgical procedures. This innovative product can be stored at room temperature for up to three years, enhancing its usability. The introduction of Hemopatch highlights Baxter's ongoing commitment to advancing surgical technologies and improving patient outcomes.
Price reaction · baseline $31.47 (2025-05-19 close) · hit after-hours · clean, no other BAX news in the window
day 0 close
0%

Market Sentiment Analysis

POSITIVE FACTORS

  • Introduction of Hemopatch represents significant innovation.
  • Product designed for effective hemostasis and hermetic sealing.
  • Suitable for open surgery and minimally invasive procedures.
  • Baxter's commitment to innovation in tissue management.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+18%
120-day peak, hindsight
Typical move
1.9%
average across 12 past catalysts
Lead asset
Dianeal
Phase 3 · End Stage Renal Disease (ESRD)

Full Press Release Details

ДИРФИЛД, штат Иллинойс , 20 мая 2025 г. /PRNewswire/ -- «Гемостатический пластырь Hemopatch представляет собой значительную разработку компании Baxter, и внедрение варианта с комнатной температурой подчеркивает нашу постоянную приверженность инновациям в управлении тканями», - заявил Стив Уоллес ( Steve Wallace ), президент по передовой хирургии в Baxter.
Основываясь на десятилетнем успехе на рынке, компания Baxter рада представить гемостатический пластырь Hemopatch , который теперь удобно храненить при комнатной температуре в течение 3 лет.

Frequently Asked Questions

What is Hemopatch?

Hemopatch is a hemostatic patch developed by Baxter for effective sealing and hemostasis.

How long can Hemopatch be stored?

Hemopatch can be stored at room temperature for up to three years.

What types of procedures is Hemopatch suitable for?

Hemopatch is suitable for open surgeries and minimally invasive surgical procedures.

What does Baxter aim to achieve with Hemopatch?

Baxter aims to enhance surgical outcomes and innovate in tissue management with Hemopatch.

ShareAdd on Google
Tags: BAX Viatris Investor Conferences Healthcare Baxter Hemopatch hemostatic patch surgical innovation tissue management
Last updated: May 20, 2025

Biotech snapshot

Cash runway
$2151M liquidity · $0M/mo burn
Low dilution risk
Lead asset
DianealPhase 3
End Stage Renal Disease (ESRD) →

Catalyst track record

+18%
best trade around BAX's most recent catalyst

Peak hindsight return over a 120-day window, across 12 tracked FDA/PDUFA catalysts for BAX.

See every catalyst's timing & PoA →